Literature DB >> 29766208

[Adequate anti-infective treatment : Importance of individual dosing and application].

A Brinkmann1, A C Röhr2, A Köberer3, T Fuchs3, W A Krüger4, C König5,6, D Richter7, M A Weigand7, O R Frey2.   

Abstract

Sepsis-induced changes in pharmacokinetic parameters are a well-known problem in intensive care medicine. Dosing of antibiotics in this setting is therefore challenging. Alterations to the substance-specific kinetics of anti-infective substances have an effect on the distribution and excretion processes in the body. Increased clearance and an increased distribution volume (Vd) and particularly compromized organ function with reduced antibiotic elimination are often encountered in patients with sepsis. Renal replacement treatment, which is frequently used in intensive care medicine, represents a substantial intervention in this system. Current international guidelines recommend individualized dosing strategies and adaptation of doses according to measured serum levels and pharmacokinetic/pharmacodynamic (PK/PD) parameters as concepts to optimize anti-infective therapy in the critically ill. Likewise, the recommendation to adjust the administration form of beta-lactam antibiotics to prolonged or continuous infusion can be found increasingly more often in the literature. This article reviews the background of the individual dosing in intensive care patients and their applicability to the clinical routine.

Entities:  

Keywords:  Drug dosage calculations; Pharmacodynamics; Pharmacokinetics; Renal replacement therapy; Sepsis and septic shock; Therapeutic drug monitoring

Mesh:

Substances:

Year:  2018        PMID: 29766208     DOI: 10.1007/s00101-018-0443-4

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  43 in total

1.  Effect of a multifaceted educational intervention for anti-infectious measures on sepsis mortality: a cluster randomized trial.

Authors:  Frank Bloos; Hendrik Rüddel; Daniel Thomas-Rüddel; Daniel Schwarzkopf; Christine Pausch; Stephan Harbarth; Torsten Schreiber; Matthias Gründling; John Marshall; Philipp Simon; Mitchell M Levy; Manfred Weiss; Andreas Weyland; Herwig Gerlach; Tobias Schürholz; Christoph Engel; Claudia Matthäus-Krämer; Christian Scheer; Friedhelm Bach; Reimer Riessen; Bernhard Poidinger; Karin Dey; Norbert Weiler; Andreas Meier-Hellmann; Helene H Häberle; Gabriele Wöbker; Udo X Kaisers; Konrad Reinhart
Journal:  Intensive Care Med       Date:  2017-05-02       Impact factor: 17.440

2.  Anti-infective drugs during continuous hemodialysis - using the bench to learn what to do at the bedside.

Authors:  Anka C Roehr; Otto R Frey; Andreas Koeberer; Thomas Fuchs; Jason A Roberts; Alexander Brinkmann
Journal:  Int J Artif Organs       Date:  2015-01-23       Impact factor: 1.595

3.  Meropenem penetration into epithelial lining fluid in mice and humans and delineation of exposure targets.

Authors:  G L Drusano; T P Lodise; D Melnick; W Liu; A Oliver; A Mena; B VanScoy; A Louie
Journal:  Antimicrob Agents Chemother       Date:  2011-05-16       Impact factor: 5.191

4.  Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious Diseases.

Authors:  K de With; F Allerberger; S Amann; P Apfalter; H-R Brodt; T Eckmanns; M Fellhauer; H K Geiss; O Janata; R Krause; S Lemmen; E Meyer; H Mittermayer; U Porsche; E Presterl; S Reuter; B Sinha; R Strauß; A Wechsler-Fördös; C Wenisch; W V Kern
Journal:  Infection       Date:  2016-06       Impact factor: 3.553

5.  An international, multicentre survey of β-lactam antibiotic therapeutic drug monitoring practice in intensive care units.

Authors:  Gloria Wong; Alexander Brinkman; Russell J Benefield; Mieke Carlier; Jan J De Waele; Najoua El Helali; Otto Frey; Stephan Harbarth; Angela Huttner; Brett McWhinney; Benoit Misset; Federico Pea; Judit Preisenberger; Michael S Roberts; Thomas A Robertson; Anka Roehr; Fekade Bruck Sime; Fabio Silvio Taccone; Jacobus P J Ungerer; Jeffrey Lipman; Jason A Roberts
Journal:  J Antimicrob Chemother       Date:  2014-01-16       Impact factor: 5.790

6.  Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients (DALI) cohort.

Authors:  Mohd H Abdul-Aziz; Jeffrey Lipman; Murat Akova; Matteo Bassetti; Jan J De Waele; George Dimopoulos; Joel Dulhunty; Kirsi-Maija Kaukonen; Despoina Koulenti; Claude Martin; Philippe Montravers; Jordi Rello; Andrew Rhodes; Therese Starr; Steven C Wallis; Jason A Roberts
Journal:  J Antimicrob Chemother       Date:  2015-10-03       Impact factor: 5.790

7.  Vancomycin-associated nephrotoxicity in the critically ill: a retrospective multivariate regression analysis*.

Authors:  Timothy P Hanrahan; Georgina Harlow; James Hutchinson; Joel M Dulhunty; Jeffrey Lipman; Tony Whitehouse; Jason A Roberts
Journal:  Crit Care Med       Date:  2014-12       Impact factor: 7.598

8.  Risk factors for target non-attainment during empirical treatment with β-lactam antibiotics in critically ill patients.

Authors:  Jan J De Waele; J Lipman; M Akova; M Bassetti; G Dimopoulos; M Kaukonen; D Koulenti; C Martin; P Montravers; J Rello; A Rhodes; A A Udy; T Starr; S C Wallis; J A Roberts
Journal:  Intensive Care Med       Date:  2014-07-23       Impact factor: 17.440

9.  Cerebrospinal fluid penetration of meropenem in neurocritical care patients with proven or suspected ventriculitis: a prospective observational study.

Authors:  Ute Blassmann; Anka C Roehr; Otto R Frey; Cornelia Vetter-Kerkhoff; Niklas Thon; William Hope; Josef Briegel; Volker Huge
Journal:  Crit Care       Date:  2016-10-24       Impact factor: 9.097

10.  DALI: defining antibiotic levels in intensive care unit patients: are current β-lactam antibiotic doses sufficient for critically ill patients?

Authors:  Jason A Roberts; Sanjoy K Paul; Murat Akova; Matteo Bassetti; Jan J De Waele; George Dimopoulos; Kirsi-Maija Kaukonen; Despoina Koulenti; Claude Martin; Philippe Montravers; Jordi Rello; Andrew Rhodes; Therese Starr; Steven C Wallis; Jeffrey Lipman
Journal:  Clin Infect Dis       Date:  2014-01-14       Impact factor: 9.079

View more
  3 in total

Review 1.  [S2k guidelines of the PEG on calculated parenteral initial treatment of bacterial diseases in adults : Focussed summary and supplementary information on antibiotic treatment of critically ill patients].

Authors:  A Brinkmann; A C Röhr; O R Frey; W A Krüger; T Brenner; D C Richter; K-F Bodmann; M Kresken; B Grabein
Journal:  Anaesthesist       Date:  2018-12       Impact factor: 1.041

2.  [New antibiotics for severe infections due to multidrug-resistant pathogens : Definitive treatment and escalation].

Authors:  D C Richter; T Brenner; A Brinkmann; B Grabein; M Hochreiter; A Heininger; D Störzinger; J Briegel; M Pletz; M A Weigand; C Lichtenstern
Journal:  Anaesthesist       Date:  2019-11       Impact factor: 1.041

3.  Antibiotic therapeutic drug monitoring in intensive care patients treated with different modalities of extracorporeal membrane oxygenation (ECMO) and renal replacement therapy: a prospective, observational single-center study.

Authors:  Dennis Kühn; Carlos Metz; Frederik Seiler; Holger Wehrfritz; Sophie Roth; Mohammad Alqudrah; André Becker; Hendrik Bracht; Stefan Wagenpfeil; Mathias Hoffmann; Robert Bals; Ulrich Hübner; Jürgen Geisel; Philipp M Lepper; Sören L Becker
Journal:  Crit Care       Date:  2020-11-25       Impact factor: 9.097

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.